Deutsche Bank Adjusts Price Target on Elevance Health to $467 From $565
Is Elevance Health, Inc. (NYSE:ELV) the Most Undervalued Value Stock to Buy According to Analysts?
Elevance Health Is Maintained at Overweight by Morgan Stanley
Elevance Health (NYSE:ELV) Could Easily Take On More Debt
Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $549
Morgan Stanley Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $551
Elevance Health: Strong Financial Performance and Strategic Value Create Attractive Investment Opportunity
Express News | Elevance Health Inc : Morgan Stanley Cuts Target Price to $551.00 From $643.00
Elevance Health Analyst Ratings
Express News | Elevance Health Files for Six-Part Notes Offering; Size Not Disclosed - SEC Filing
Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $501
Barclays Remains a Buy on Elevance Health (ELV)
Decoding 11 Analyst Evaluations For Elevance Health
Correction to Saturday Heard on the Street Article About Health Insurers -- WSJ
Elevance Health Is Maintained at Buy by TD Cowen
Leerink Partners Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $515
Jefferies Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $529
Elevance Health: Navigating Challenges and Opportunities With a Positive Outlook
Jefferies Adjusts Price Target on Elevance Health to $529 From $600, Maintains Buy Rating
TD Cowen Initiates Elevance Health(ELV.US) With Buy Rating, Announces Target Price $484